ID   CLP1_MOUSE              Reviewed;         425 AA.
AC   Q99LI9; Q3TEC7; Q3ULZ9;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   07-APR-2021, entry version 122.
DE   RecName: Full=Polyribonucleotide 5'-hydroxyl-kinase Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};
DE            EC=2.7.1.78 {ECO:0000255|HAMAP-Rule:MF_03035};
DE   AltName: Full=Polyadenylation factor Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};
DE   AltName: Full=Polynucleotide kinase Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};
DE   AltName: Full=Pre-mRNA cleavage complex II protein Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};
GN   Name=Clp1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Embryo, Mammary gland, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF LYS-127.
RX   PubMed=23474986; DOI=10.1038/nature11923;
RA   Hanada T., Weitzer S., Mair B., Bernreuther C., Wainger B.J., Ichida J.,
RA   Hanada R., Orthofer M., Cronin S.J., Komnenovic V., Minis A., Sato F.,
RA   Mimata H., Yoshimura A., Tamir I., Rainer J., Kofler R., Yaron A.,
RA   Eggan K.C., Woolf C.J., Glatzel M., Herbst R., Martinez J., Penninger J.M.;
RT   "CLP1 links tRNA metabolism to progressive motor-neuron loss.";
RL   Nature 495:474-480(2013).
RN   [4]
RP   FUNCTION, AND MUTAGENESIS OF LYS-127.
RX   PubMed=24766809; DOI=10.1016/j.cell.2014.02.058;
RG   Baylor Hopkins Center for Mendelian Genomics;
RA   Karaca E., Weitzer S., Pehlivan D., Shiraishi H., Gogakos T., Hanada T.,
RA   Jhangiani S.N., Wiszniewski W., Withers M., Campbell I.M., Erdin S.,
RA   Isikay S., Franco L.M., Gonzaga-Jauregui C., Gambin T., Gelowani V.,
RA   Hunter J.V., Yesil G., Koparir E., Yilmaz S., Brown M., Briskin D.,
RA   Hafner M., Morozov P., Farazi T.A., Bernreuther C., Glatzel M.,
RA   Trattnig S., Friske J., Kronnerwetter C., Bainbridge M.N., Gezdirici A.,
RA   Seven M., Muzny D.M., Boerwinkle E., Ozen M., Clausen T., Tuschl T.,
RA   Yuksel A., Hess A., Gibbs R.A., Martinez J., Penninger J.M., Lupski J.R.;
RT   "Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and
RT   central nervous system function.";
RL   Cell 157:636-650(2014).
CC   -!- FUNCTION: Polynucleotide kinase that can phosphorylate the 5'-hydroxyl
CC       groups of double-stranded RNA (dsRNA), single-stranded RNA (ssRNA),
CC       double-stranded DNA (dsDNA) and double-stranded DNA:RNA hybrids. dsRNA
CC       is phosphorylated more efficiently than dsDNA, and the RNA component of
CC       a DNA:RNA hybrid is phosphorylated more efficiently than the DNA
CC       component. Plays a key role in both tRNA splicing and mRNA 3'-end
CC       formation. Component of the tRNA splicing endonuclease complex:
CC       phosphorylates the 5'-terminus of the tRNA 3'-exon during tRNA
CC       splicing; this phosphorylation event is a prerequisite for the
CC       subsequent ligation of the two exon halves and the production of a
CC       mature tRNA (PubMed:23474986, PubMed:24766809). Its role in tRNA
CC       splicing and maturation is required for cerebellar development
CC       (PubMed:24766809). Component of the pre-mRNA cleavage complex II (CF-
CC       II), which seems to be required for mRNA 3'-end formation. Also
CC       phosphorylates the 5'-terminus of exogenously introduced short
CC       interfering RNAs (siRNAs), which is a necessary prerequisite for their
CC       incorporation into the RNA-induced silencing complex (RISC). However,
CC       endogenous siRNAs and microRNAs (miRNAs) that are produced by the
CC       cleavage of dsRNA precursors by DICER1 already contain a 5'-phosphate
CC       group, so this protein may be dispensible for normal RNA-mediated gene
CC       silencing. {ECO:0000269|PubMed:23474986, ECO:0000269|PubMed:24766809}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5'-dephospho-(DNA) + ATP = ADP + H(+) + phospho-5'-(DNA);
CC         Xref=Rhea:RHEA:15669, Rhea:RHEA-COMP:13180, Rhea:RHEA-COMP:13184,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:136412,
CC         ChEBI:CHEBI:136416, ChEBI:CHEBI:456216; EC=2.7.1.78;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03035};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5'-dephospho-(RNA) + ATP = 5'-end-(RNA) + ADP + H(+);
CC         Xref=Rhea:RHEA:54580, Rhea:RHEA-COMP:13935, Rhea:RHEA-COMP:13936,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:138282,
CC         ChEBI:CHEBI:138284, ChEBI:CHEBI:456216; EC=2.7.1.78;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03035};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03035};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03035};
CC       Name=Ni(2+); Xref=ChEBI:CHEBI:49786;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03035};
CC   -!- SUBUNIT: Component of the tRNA splicing endonuclease complex, composed
CC       of CLP1, TSEN2, TSEN15, TSEN34 and TSEN54. Component of pre-mRNA
CC       cleavage complex II (CF-II). Also associates with numerous components
CC       of the pre-mRNA cleavage complex I (CF-I/CFIm), including NUDT21,
CC       CPSF2, CPSF3, CPSF6 and CPSF7. Interacts with CSTF2 and SYMPK.
CC       {ECO:0000255|HAMAP-Rule:MF_03035}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03035}.
CC   -!- DISRUPTION PHENOTYPE: Early embryonic lethality.
CC       {ECO:0000269|PubMed:23474986}.
CC   -!- SIMILARITY: Belongs to the Clp1 family. Clp1 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03035}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK077647; BAC36924.1; -; mRNA.
DR   EMBL; AK145209; BAE26299.1; -; mRNA.
DR   EMBL; AK169709; BAE41321.1; -; mRNA.
DR   EMBL; BC003237; AAH03237.1; -; mRNA.
DR   CCDS; CCDS16191.1; -.
DR   RefSeq; NP_598601.1; NM_133840.2.
DR   SMR; Q99LI9; -.
DR   BioGRID; 221164; 9.
DR   IntAct; Q99LI9; 9.
DR   STRING; 10090.ENSMUSP00000028475; -.
DR   iPTMnet; Q99LI9; -.
DR   PhosphoSitePlus; Q99LI9; -.
DR   EPD; Q99LI9; -.
DR   MaxQB; Q99LI9; -.
DR   PaxDb; Q99LI9; -.
DR   PeptideAtlas; Q99LI9; -.
DR   PRIDE; Q99LI9; -.
DR   ProteomicsDB; 283860; -.
DR   Antibodypedia; 27467; 191 antibodies.
DR   DNASU; 98985; -.
DR   Ensembl; ENSMUST00000028475; ENSMUSP00000028475; ENSMUSG00000027079.
DR   Ensembl; ENSMUST00000165219; ENSMUSP00000129300; ENSMUSG00000027079.
DR   GeneID; 98985; -.
DR   KEGG; mmu:98985; -.
DR   UCSC; uc008kja.1; mouse.
DR   CTD; 10978; -.
DR   MGI; MGI:2138968; Clp1.
DR   eggNOG; KOG2749; Eukaryota.
DR   GeneTree; ENSGT00940000153668; -.
DR   HOGENOM; CLU_018195_1_0_1; -.
DR   InParanoid; Q99LI9; -.
DR   OMA; KVAIFTY; -.
DR   OrthoDB; 814241at2759; -.
DR   PhylomeDB; Q99LI9; -.
DR   TreeFam; TF105795; -.
DR   Reactome; R-MMU-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-MMU-72187; mRNA 3'-end processing.
DR   Reactome; R-MMU-73856; RNA Polymerase II Transcription Termination.
DR   Reactome; R-MMU-77595; Processing of Intronless Pre-mRNAs.
DR   BioGRID-ORCS; 98985; 22 hits in 51 CRISPR screens.
DR   PRO; PR:Q99LI9; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q99LI9; protein.
DR   Bgee; ENSMUSG00000027079; Expressed in spermatid and 301 other tissues.
DR   Genevisible; Q99LI9; MM.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005849; C:mRNA cleavage factor complex; IEA:UniProtKB-UniRule.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0000214; C:tRNA-intron endonuclease complex; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0046404; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0051736; F:ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity; ISS:UniProtKB.
DR   GO; GO:0051733; F:polydeoxyribonucleotide kinase activity; ISS:UniProtKB.
DR   GO; GO:0051731; F:polynucleotide 5'-hydroxyl-kinase activity; IBA:GO_Central.
DR   GO; GO:0021695; P:cerebellar cortex development; IMP:UniProtKB.
DR   GO; GO:0006378; P:mRNA polyadenylation; IBA:GO_Central.
DR   GO; GO:0006396; P:RNA processing; IBA:GO_Central.
DR   GO; GO:0035087; P:siRNA loading onto RISC involved in RNA interference; ISS:UniProtKB.
DR   GO; GO:0030423; P:targeting of mRNA for destruction involved in RNA interference; ISS:UniProtKB.
DR   GO; GO:0006388; P:tRNA splicing, via endonucleolytic cleavage and ligation; ISS:UniProtKB.
DR   Gene3D; 2.60.120.1030; -; 1.
DR   Gene3D; 3.30.70.2410; -; 1.
DR   HAMAP; MF_03035; Clp1; 1.
DR   InterPro; IPR028606; Clp1.
DR   InterPro; IPR010655; Clp1_C.
DR   InterPro; IPR038238; Clp1_C_sf.
DR   InterPro; IPR032324; Clp1_N.
DR   InterPro; IPR038239; Clp1_N_sf.
DR   InterPro; IPR032319; CLP1_P.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF06807; Clp1; 1.
DR   Pfam; PF16573; CLP1_N; 1.
DR   Pfam; PF16575; CLP1_P; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Kinase; Magnesium; Manganese; mRNA processing;
KW   Neurodegeneration; Nickel; Nucleotide-binding; Nucleus; Reference proteome;
KW   Transferase; tRNA processing.
FT   CHAIN           1..425
FT                   /note="Polyribonucleotide 5'-hydroxyl-kinase Clp1"
FT                   /id="PRO_0000089864"
FT   NP_BIND         124..129
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03035"
FT   BINDING         22
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03035"
FT   BINDING         62
FT                   /note="ATP; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03035"
FT   MUTAGEN         127
FT                   /note="K->A: Progressive loss of motor neurons, axonal
FT                   motor neuropathy, and muscle paralysis leading to death
FT                   within hours of birth. Mice exhibit microcephaly due to
FT                   reduced numbers of cortical neurons. Embryos have normal
FT                   numbers and proliferation of neuronal progenitors, but
FT                   neuronal progenitor cells undergo enhanced cell death,
FT                   resulting in reduced numbers of cortical neurons."
FT                   /evidence="ECO:0000269|PubMed:23474986,
FT                   ECO:0000269|PubMed:24766809"
FT   CONFLICT        79
FT                   /note="T -> N (in Ref. 1; BAE26299)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        264
FT                   /note="N -> D (in Ref. 1; BAE41321)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        394
FT                   /note="V -> L (in Ref. 1; BAE26299)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   425 AA;  47738 MW;  C1AED7978B383097 CRC64;
     MSEESNDDKK PTTKFELERE TELRFEVEAS QSVQLELLAG MAEIFGTELT RNKKFTFDAG
     AKVAVFTWHG CSLQLSGRTE VAYVSKDTPM LLYLNTHTAL EQMRRQAEKE EERGPRVMVV
     GPTDVGKSTV CRLLLNYAVR LGRRPTYVEL DVGQGSVSIP GTMGALYIER PADVEEGFSI
     QAPLVYHFGS TTPGTNIKLY NKITSRLADV FNQRCEVNRR ASVSGCVINT CGWVKGYGYQ
     ALVHAASAFE VDVVVVLDQE RLYNELKRDL PHFVRTVLLP KSGGVVERSK DFRRECRDER
     IREYFYGFRG CFYPHAFNVK FSDVKIYKVG APTIPDSCLP LGMSQEDNQL KLVPVTPGRD
     MVHHLLSVST AEGTEENLSE TSVAGFIVVT SVDVEHQVFT VLSPAPRPLP KNFLLIMDIR
     FMDLK
//
